Ligand Pharmaceuticals IncNASDAQ:LGND
- LAST PRICE114.1800
- TODAY'S CHANGE (%)0.5000 (0.4398%)
- Bid / Lots54.7600/ 1
- Ask / Lots174.0000/ 1
- Open / Previous Close111.7100 / 113.6800
- Day Range
- 52 Week Range
- Volume200,427
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LGND |
|---|---|---|
| 09:32 ET | 3958 | 111.4074 |
| 09:33 ET | 5000 | 111.6484 |
| 09:42 ET | 100 | 112.83 |
| 09:48 ET | 272 | 113.4132 |
| 09:50 ET | 100 | 114.625 |
| 10:02 ET | 222 | 114.82 |
| 10:04 ET | 2422 | 114.11 |
| 10:13 ET | 600 | 113.66 |
| 10:15 ET | 1603 | 114.26 |
| 10:20 ET | 100 | 114.43 |
| 10:26 ET | 200 | 114.75 |
| 10:31 ET | 900 | 116.075 |
| 10:33 ET | 800 | 116.24 |
| 10:38 ET | 100 | 116.99 |
| 10:40 ET | 100 | 116.83 |
| 10:42 ET | 100 | 117.22 |
| 10:45 ET | 600 | 115.7904 |
| 10:51 ET | 800 | 117.64 |
| 10:54 ET | 200 | 117.345 |
| 10:56 ET | 100 | 117.58 |
| 10:58 ET | 150 | 118.355 |
| 11:00 ET | 200 | 116.89 |
| 11:02 ET | 100 | 117.145 |
| 11:03 ET | 100 | 116.68 |
| 11:05 ET | 100 | 116.75 |
| 11:07 ET | 300 | 117.8405 |
| 11:09 ET | 2500 | 117.4739 |
| 11:12 ET | 300 | 117.25 |
| 11:20 ET | 100 | 116.84 |
| 11:21 ET | 200 | 116.57 |
| 11:23 ET | 700 | 116.99 |
| 11:27 ET | 200 | 116.82 |
| 11:30 ET | 600 | 116.76 |
| 11:32 ET | 200 | 116.43 |
| 11:34 ET | 300 | 116.89 |
| 11:38 ET | 400 | 115.97 |
| 11:48 ET | 100 | 115.325 |
| 11:50 ET | 3289 | 115 |
| 11:52 ET | 400 | 115.77 |
| 11:54 ET | 100 | 116.17 |
| 12:10 ET | 200 | 116.16 |
| 12:12 ET | 100 | 115.95 |
| 12:14 ET | 100 | 115.05 |
| 12:17 ET | 1391 | 115 |
| 12:19 ET | 3225 | 115.1077 |
| 12:24 ET | 500 | 115.67 |
| 12:30 ET | 100 | 116.17 |
| 12:35 ET | 100 | 116.77 |
| 12:37 ET | 100 | 117 |
| 12:50 ET | 100 | 117.135 |
| 12:51 ET | 117 | 116.5129 |
| 12:55 ET | 400 | 116.64 |
| 01:00 ET | 600 | 117.085 |
| 01:02 ET | 1600 | 116.4501 |
| 01:04 ET | 100 | 116.78 |
| 01:09 ET | 100 | 116.41 |
| 01:27 ET | 100 | 115.21 |
| 01:29 ET | 1330 | 115.07 |
| 01:31 ET | 358 | 115.0646 |
| 01:33 ET | 100 | 115.31 |
| 01:38 ET | 100 | 115.2 |
| 01:42 ET | 1488 | 115.27 |
| 01:44 ET | 831 | 115.415 |
| 01:49 ET | 100 | 115 |
| 01:51 ET | 315 | 115.48 |
| 01:54 ET | 100 | 115.18 |
| 01:56 ET | 449 | 115.2506 |
| 01:58 ET | 100 | 115.31 |
| 02:05 ET | 100 | 115 |
| 02:09 ET | 100 | 114.93 |
| 02:14 ET | 8298 | 115.35 |
| 02:23 ET | 100 | 115.44 |
| 02:25 ET | 110 | 115.45 |
| 02:27 ET | 600 | 114.87 |
| 02:30 ET | 2100 | 115.31 |
| 02:36 ET | 200 | 114.84 |
| 02:38 ET | 100 | 115.33 |
| 02:39 ET | 200 | 115.33 |
| 02:41 ET | 100 | 115.49 |
| 02:48 ET | 800 | 115.12 |
| 02:50 ET | 200 | 115.15 |
| 02:54 ET | 2817 | 115.01 |
| 02:56 ET | 100 | 115 |
| 02:57 ET | 200 | 114.78 |
| 03:01 ET | 300 | 114.88 |
| 03:03 ET | 1100 | 115.11 |
| 03:06 ET | 197 | 115.2 |
| 03:08 ET | 1879 | 115 |
| 03:10 ET | 304 | 115.01 |
| 03:12 ET | 2609 | 114.82 |
| 03:14 ET | 200 | 114.56 |
| 03:15 ET | 115 | 114.3501 |
| 03:17 ET | 200 | 114.74 |
| 03:24 ET | 200 | 115.5597 |
| 03:28 ET | 400 | 115.35 |
| 03:30 ET | 420 | 115.15 |
| 03:33 ET | 500 | 115.39 |
| 03:35 ET | 446 | 115.27 |
| 03:37 ET | 5373 | 115.65 |
| 03:39 ET | 775 | 115.9 |
| 03:42 ET | 300 | 116.05 |
| 03:44 ET | 2200 | 116.545 |
| 03:46 ET | 600 | 115.32 |
| 03:48 ET | 6870 | 115 |
| 03:50 ET | 300 | 115.29 |
| 03:51 ET | 1198 | 114.92 |
| 03:55 ET | 1816 | 114.81 |
| 03:57 ET | 4982 | 114.74 |
| 04:00 ET | 46904 | 114.18 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ligand Pharmaceuticals Inc | 1.9B | 28.6x | --- |
CareDx Inc | 2.0B | -106.6x | --- |
Nektar Therapeutics | 2.0B | -4.0x | --- |
Veracyte Inc | 1.9B | -23.7x | --- |
Agios Pharmaceuticals Inc | 1.6B | -5.4x | --- |
Travere Therapeutics Inc | 1.6B | -5.6x | --- |
Company Information
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company. The Company is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's technology includes Captisol Technology, OmniAb Technologies (OMT), Icagen Ion Channel Technology Platform, Pelican Expression Technology platform and Liver Targeting Prodrug (LTP) Technology to assist companies in their work toward securing prescription drug and biologic approvals. It has partnerships and license agreements with over 130 pharmaceutical and biotechnology companies and over 300 programs that are in various stages of commercialization, development or research and are fully funded by its collaboration partners and licensees. Its partners and licensees have programs in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.
Contact Information
- Headquarters
- 3911 Sorrento Valley Blvd Ste 110SAN DIEGO, CA, United States 92121-1402
- Phone
- 858-550-7500
- Fax
- 302-636-5454
Executives
- Non-Executive Independent Chairman of the Board
- John Kozarich
- President, Chief Operating Officer
- Matthew Foehr
- Chief Executive Officer, Director
- John Higgins
- Chief Financial Officer, Executive Vice President - Finance
- Matthew Korenberg
- Senior Vice President, General Counsel, Secretary
- Charles Berkman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
|---|---|
Revenue (TTM) | $274.7M |
Shares Outstanding | 16.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.14 |
EPS | $4.00 |
Book Value | $44.12 |
P/E Ratio | 28.6x |
Price/Sales (TTM) | 6.9 |
Price/Cash Flow (TTM) | 16.0x |
Operating Margin | 25.55% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
